Nanomix Corporation (OTCMKTS:NNMX) Stock In Focus After A New Appointment
Nanomix Corporation (OTCMKTS:NNMX) announced on August 31, 2022, about appointing Tadd S. Lazarus, M.D., to the Board of Directors as an independent director. Having begun his career at Roche Diagnostics, he has held simultaneous roles in private practice and as Director of Medical and Scientific Affairs, and then as the North American Medical Director for the molecular diagnostics, POC, diabetes, clinical chemistry, and immunology lines of business. Trading Data On…